The Effects of Coffee Consumption on Cardiovascular Heart Diseases and Other Diseases

Year 2019, Volume: 12 Issue: 2, 25 - 31, 29.12.2019

Sara Çetin Şanlıalp , Ali Ertekin

Abstract

Coffee is the most consumed drinks in daily life
after tea and water. Coffee has become an indispensable part of our
sociocultural life. Most people start their day with coffee and finish with
this. Coffee can be called superfood because it has many bioactive components,
minerals and vitamins that affect human health. Therefore, coffee has attracted
the attention of many researchers with its rich bioactive components and then studies
about the effects of coffee on animal and human health have been realized. In
this review, we aimed to investigate the effects of coffee on health,
especially cardiovascular disease (CVD) and cardiovascular risk factors.

Keywords

Antioxidant; Bioactive Components; Cardiovascular Diseases; Coffee; Health

References

• 1. Andersen LF, Jacobs D, Carlsen M, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and Cardiovascular diseases in the Iowa. Women’s Health Study. Am J Clin Nutr.2006;83(5):1039-46.
• 2. Arab L. Epidemiologic Evidenceon Coffee and Cancer. Nutr Cancer. 2010;62:271–283.
• 3. Arion WJ, Canfield WK, Ramos FC et al. Chlorogenic acid and hydroxynitrobenzaldehyde: New inhibitors of hepatic glucose 6-phosphatase. Arch. Biochem Biophys. 1997;339:315–322.
• 4. Ascherio A, Chen H. Caffeinated clues from epidemiology of Parkinson’s disease. Neurology. 2003; 61:51–54.
• 5. Bae JH, Park JH, Im SS, Song DY. Coffee and health, Integr Med Res. 2014; 3:189-191.
• 6. Bonita JS, Mandarano M, Shuta D, Vinson J. Coffee and cardiovascular disease: in vitro, cellular, animal, and human studies. Pharmacol Res. 2007;55:187–98.
• 7. Boswell-Smith V, Spina D et al. Phosphodiesterase inhibitors. Br J Pharmacol. 2009; 147:252–257.
• 8. Carlsson S, Hammar N, Grill V et al. Coffee consumption and risk of type 2 diabetes in Finnish twins. Int J Epidemiol. 2004; 33:616–617.
• 9. Chung TW, Moon SK, Chang YC et al. Noveland therapeutic effect of caffeicacid and caffeic acid phenylesteron hepato carcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. Faseb J. 2004;18:1670–1681.
• 10.D’Elia L,Cairella G,Garbagnati F,Scalfi L,Strazzullo P. Moderate coffee consumption is associated with lower risk of stroke:meta- analysis of prospective studies. J Hypertens. 2012:e107.
• 11. DeRoos B, Sawyer JK et al.Validity of animal models for the cholesterol-raising effects of coffee diterpenes in human subjects. Proc. Nutr. Soc. 1999;58: 551–557.
• 12. Dews PB, Curtis GL et al. The frequency of caffeine withdrawal in a population-based survey and in a controlled, blinded pilot experiment. J Clin Pharmacol. 1999; 39:1221– 1232.
• 13. Engebretsen KM, Harris CR. Caffeine and related non- prescription sympathomimetics. In Clinical Toxicology. 2001; 310–315.
• 14. Ferré S, Fredholm BB, Morelli M et al. Adenosine-dopaminereceptor-receptorinteractions as an integrative mechanism in the basal ganglia. Trends Neuro Sci. 1997; 20: 482–487.
• 15. Frost-Meyer NJ, Logomarsino JV. Impact of coffee components on inflammatory markers: Areview. J Funct Foods. 2012;4: 819–830.
• 16. Gilbert RM, Marshman JA, Schwieder M, Berg R. Caffeine content of beverages as consumed. Can Med Assoc J. 1976; 114: 205–208.
• 17. Giovannucci E. Meta-analysis of coffee consumption and risk of colorectal cancer. Am J Epidemiol. 1998;147:1043–1052.
• 18. Glei M, Kirmse A, Habermann N et al. Bread enriched with green coffee extract has chemoprotective and antigenotoxic activities in human cells. Nutr Cancer. 2006; 56: 182–192.
• 19. Greenberg J, Dunbar C, Roseanne S, Kokolis R, Kokolis S, Kassotis J. Caffeinated beverage intake and the risk of heart disease mortality in the elderly: a prospective analysis. Am J Clin Nutr. 2007;85(2):392-8.
• 20. Grobbee DE et al. The effect on serum cholesterol levels of coffee brewed by filtering or boiling. N Engl J Med.1989;321:1432–7.
• 21. Gross G, Jaccaud E, Huggett AC. Analysis of the content of the diterpenes cafestol and kahweolin coffee brews. Food Chem. Toxicol. 1997; 35 :547–554.
• 22. Hallström H, Byberg L et al. Long-term Coffee Consumption in Relation to Fracture Risk and Bone Mineral Density in Women. Am J Epidemiol. 2013;178:898–909.
• 23. Heaney R. Effects of caffeine on bone and the calcium economy. Food Chem. Toxicol. 2002;40:1263–1270.
• 24. Higdon JV and Freı B. Coffee and Health: A review of Recent Human Research. Food Science and Nutrition. 2006;46:101-123.
• 25. Holtzman SG, Mante S, Minneman KP. Role of adenosine in caffeine tolerance. J. Pharmacol Exp Ther. 1991; 256: 62–68.
• 26. Huber WW, McDaniel LP et al. Chemoprotection against the formation of colon DNA adducts from the food-borne carcinogen 2-amino-1-methyl-6- phenylimidazol[4,5-b] pyridine (PhIP) in the rat. Mutat. Res. 1997; 376: 115–122.
• 27. Husemoen LL, ThomsenTF, Fenger M, JorgensenT. Effect of lifestyle factors on plasma total homocysteine concentrations in relation toMTHFR (C677T) genotype. Eur. J. Clin. Nutr. 2004;58:1142–1150.
• 28. Inoue M, YoshimiI, SobueT, Tsugane S. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: A prospective study in Japan. Journal of the National Cancer Institute. 2005;97(293):293-300.
• 29. International Coffee Organization (ICO). Coffee Market Report, December 2018; ICO: London, UK, 2018; Available online:http://www.ico.org/Market-Report-18-19-e.asp(accessed on 11 February2019).
• 30. International Coffee Organization(ICO). Infographics on the Global Coffee Trade. Available online: http:// www.ico.org/coffee-trade-statistics-infographics.asp? Section =Statistics (assessed on 1 March 2016).
• 31. Jane V, Hıgdon Balz Freı . Coffee and Health A review of Recent Human Research. Food Science and Nutrition. 2006;46:101-123.
• 32. Kawachi I, Willett WC, Colditz GA, Stampfer MJ, Speizer FE. A prospective study of coffee drinking and suicide in women. Arch Intern Med. 1996;156:521–5.
• 33. Klatsky AL, Hasan AS, Armstrong MA, Udaltsova N, Morton C. Coffee, caffeine, and risk of hospitalization for arrhythmias. Perm J. 2011;15:19–25.
• 34. Lee DR, Lee J, Rota MD et al. Coffee consumption and risk of fractures: A systematic review and dose–response meta-analysis. Bone. 2014 ; 63:20–28.
• 35. Lopez-Garcia E, van Dam RM,Willett WC et al.Coffee consumption and coronary heart disease in men and women: a prospectivecohort study. Circulation. 2006;113:2045–53.
• 36. Lopez-Garcia E,van Dam RM, Li TY et al. The relationship of coffee consumption with mortality. Ann Intern Med. 2008;148:904–14.
• 37. Louarn J, Dussert S, Guyot B et al. Caffeine, trigonelline, chlorogenic acids and sucrose diversity in wild. Coffea arabica L.and C.canephora P. accessions. Food Chem. 2001;75:223–230.
• 38. Martini D, Tassotti M, Riso P et al. Coffee Consumption and Oxidative Stress: A Review of Human Intervention Studies Molecules. 2016;21(8):979 https://doi.org/10.3390/molecules 210809979.
• 39. Mendelsohn MJ. Monoamine Oxidase Inhibitors. In ClinicalToxicology. 2001;546–557.
• 40. Mesas AE, Leon-Munoz LM, Rodriguez-Artalejo F, Lopez-Garcia E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr. 2011;94:1113–26.
• 41. Mitani T,NaganoT, Harada K et al. Caffeine-Stimulated Intestinal Epithelial Cells Suppress Lipid Accumulation in Adipocytes. J Nutr Sci Vitaminol. 2017; 63: 331–338.
• 42. Mohan Rao C, Ciudad CJ, Noé V, Izquierdo-Pulido M. Coffee polyphenols change the expression of STAT5B and ATF-2 modifying cyclin D1 levels in cancer cells. Oxid Med Cell. Longev. 2012. Article ID:390385, 17 pp, doi:10.1155/2012/390385
• 43. Mostofsky E,Rice MS, Levitan EB, Mittleman MA. Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis.Circ Heart Fail.2012;5:401–5.
• 44. Namdar M, Schepis T, Koepfli P et al. Caffeine impairs myocardial blood flow response to physical exercise in patients with coronary artery disease as well as in age-matched controls. PLoSONE. 2009;4:1–6.
• 45. Namdar OG, Modell JG, Hariharan M. Caffeine and human cerebral blood flow: A positron emission tomography study. Life Sci. 1990;47:1141–1146.
• 46. Nawrot P, Jordan S, Eastwood J et al. Effects of caffeine on human health. Food Addit Contam. 2003;20:1–30.
• 47. Newcombe PF, Renton KW, Rautaharju PM, Spencer CA, Montague TJ. High-dose caffeine and cardiac rate and rhythm in normal subjects. Chest. 1988;94:90–4.
• 48. Richardson T, Baker J,Thomas PW, Meckes C,Rozkovec A,Kerr D. Randomized control trial investigating the influence of coffee on heart rate variability in patients with ST-segment elevation myocardial infarction. Q J Med.2009;102:555–61.
• 49. Robertson WC, Stampfer MJ, Willett WC, Curhan GC. Habitual caffeine intake and the riskofhypertension in women. JAMA. 2005;294:2330–5.
• 50. Robertson D, Wade D, Workman R, Woosley RL, Oates JA.Toler-ance to the humoral and hemodynamic effects of caffeine in man .J Clin Invest1981;67:1111–7.
• 51. Sato Y, Itagaki S, Kurokawa T et al. In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid. Int J Pharm. 2011; 403:136–138.
• 52. Schwarzschild MA, Chen J, Ascherio A. Caffeinated clues and the promise of adenosine A(2A)antagonists in PD. Neurology. 2002;58:1154-1160.
• 53. S HS, Satsu H, Bae MJ et al. Anti-inflammatory effect of chlorogenic acid on the IL-8 production in Caco-2 cells and the dextran sulphate sodium-induced colitis symptoms in C57BL/6 mice. Food Chem. 2015;168:167–175.
• 54. Spiller MA. The chemical components of coffee. Prog Clin Biol Res.1984;158:91–147.
• 55. Sukyoung Choi et al. Effects of coffee extracts with different roasting degrees on antioxidant and anti-inflammatory systems in mice. Nutrients. 2018, 10(3), 363; http://doi.org/10.3390/nu10030363.
• 56. Tse WS, Chan CCS et al. Caffeinated coffee enhances co-operative behavior in the Mixed Motive Game in healthy volunteers. Nutr Neurosci. 2009;12: 21–27.
• 57. Tverdal A, Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol. 2003;13:419–423.
• 58. Upadhyay R, Mohan Rao LJ. An Outlook on Chlorogenic Acids-Occurrence, Chemistry, Technology, and Biological Activities. Crit Rev Food Sci Nutr. 2013; 53: 968–984.
• 59. Urgert R, van Vliet T, Zock PL, Katan MB. Heavy coffee consumption and plasma homocysteine:A randomized controlled trial in healthy volunteers. Am J Clin Nutr. 2000; 72:1107–1110 .
• 60. Urgert R, Katan MB. The cholesterol-raising factor from coffee beans. Annu Rev Nutr. 1997;17:305–24.
• 61. Van Dam RM, Feskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. Lancet. 2002;360:1477–1478.
• 62. Wang L, Shen X, WuY,Zhang D. Coffee and caffeine consumption and depression: A meta-analysis of observational studies. Aust N. Z. J. Psychiatry. 2016;50:228–242.
• 63. Wedick NM, Brennan AM, Sun Q, Hu FB, Mantzoros CS, Van Dam RM. Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes:a randomized controlled trial .NutrJ.2011;10:93–101.
• 64. Welsch CA, Lachance PA, Wasserman BP. Dietary phenolic compounds: Inhibition of Na+-dependent D-glucose uptake in rat intestinal brush border membrane vesicles. J Nutr. 1989;119:1698–1704.
• 65. Wikoff D, Welsh BT, Henderson R et al. Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. Food Chem. Toxicol. 2017;109:585–648.
• 66. Wilhelmsen L, Rosengren A, Lappas, G. Hospitalizations for atrial fibrillation in the general male population: Morbidity and risk factors. J Intern Med. 2001;250:382–389.
• 67. Wu JN, Ho SC, Zhou C et al. Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohortstudies. Int J Cardiol.2009;137:216–25.